MedPath
NMPA Approval

Compound Ipratropium Bromide Solution for Inhalation

国药准字H20233965

July 25, 2023

Drug Information

吸入用复方异丙托溴铵溶液

吸入制剂

2.5ml:异丙托溴铵0.5mg(按C₂₀H₃₀BrNO₃计)与沙丁胺醇2.5mg(按C₁₃H₂₁NO₃计)

化学药品

July 25, 2023

Company Information

Applicant Company

江西省南昌市南昌高新技术产业开发区瑶湖北大道3333号济民可信总部及新药产业化基地项目(一期)质检楼1层

Manufacturing Company

江西省南昌市南昌高新技术产业开发区瑶湖北大道3333号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

吸入用复方异丙托溴铵溶液 - NMPA 批准文号 | MedPath